H-11B6

N/A

Report date: 2025/11/21 17:15:17

Base Information

Drug NameH-11B6
Drug Alias Name[225Ac]hu-11B6hu-11B6h-11B6
ClassificationBiologicsRadiation-emitting products > Radioactive therapeutic agentDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5] 
Mechanisms of ActionIonising radiation emittersRadionuclide imaging enhancersKallikrein 2 inhibitors
TargetsKallikrein 2
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesDiaprost
China Registration ClassN/A

Develop Information

Active CompaniesDiaprost
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A